Nematoda infectious disease
MONDO:0005871Infections caused by nematode larvae which never develop into the adult stage and migrate through various body tissues. They commonly infect the skin, eyes, and viscera in humans. Ancylostoma brasiliensis causes cutaneous larva migrans. Toxocara causes visceral larva migrans.
Also known as: Nematoda caused disease or disorder, Nematoda disease or disorder, disease due to nematoda, Disease due to Nematoda, Infection, Nematode, Infections, Nematode, Nematode Infection, Nematode Infections
27 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New drug moxidectin put to the test against river blindness in massive safety trial
Disease control CompletedThis large Phase 3 trial compared the safety of a single dose of moxidectin versus ivermectin in nearly 13,000 people living in areas where river blindness is common. Some participants also received albendazole for lymphatic filariasis. The goal was to see if moxidectin causes fe…
Phase: PHASE3 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New combo drug doses aim to wipe out whipworm in toddlers
Disease control CompletedThis study tested whether higher doses of ivermectin, combined with albendazole, are safe and effective for treating whipworm infections in children aged 2 to 5 years. The trial involved 260 children in Tanzania and compared different doses of ivermectin, including a new dissolva…
Phase: PHASE2 • Sponsor: Jennifer Keiser • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a Two-Drug punch finally knock out whipworm in kids?
Disease control CompletedThis study tested whether combining two drugs—moxidectin and albendazole—works better than albendazole alone for treating whipworm infections in children aged 6 to 12. The trial took place in Tanzania and involved 224 children. Researchers measured how many children were cured an…
Phase: PHASE3 • Sponsor: Jennifer Keiser • Aim: Disease control
Last updated Jun 26, 2026 19:06 UTC
-
River blindness drug trial aims to find right dose for kids
Disease control CompletedThis study tested a single dose of moxidectin in 36 children aged 4 to 17 who have or are at risk of onchocerciasis (river blindness). The goal was to find a dose for children 4-11 years that works like the standard 8 mg dose used in older kids and adults. Researchers measured dr…
Phase: PHASE1 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 26, 2026 13:56 UTC
-
Which test best uncovers the sleeping parasite?
Diagnosis CompletedThis study looked at three different blood tests (ELISA) for diagnosing strongyloidiasis, an infection caused by a parasite that can stay hidden in the body. Researchers tested 80 adult patients who had previously had a positive or borderline result. The goal was to see which tes…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Do fish workers get more allergies? new study investigates
Knowledge-focused CompletedThis completed study looked at how common fish allergy is among people who work with fish, like fishermen and fish-processing factory workers, compared to other workers. Researchers surveyed 486 people in Boulogne-sur-Mer, France, asking about allergic symptoms and exposure to fi…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC